glycyrrhizic acid has been researched along with Hepatitis, Viral, Human in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, H; Ling, Q; Shi, G; Zheng, J | 1 |
| Li, YR; Wang, LX; Wang, YY; Wang, ZY; Xie, YM; Yang, W; Yi, DH | 1 |
| Ma, K; Wang, YY; Xie, YM; Yang, W; Yi, DH; Zhuang, Y | 1 |
| Chen, YP; DI, JB; Shi, HF; Xu, ZW | 1 |
| Endo, Y; Funaki, N; Hashimoto, N; Hayashi, S; Hayashida, N; Ikeda, Y; Iwabuchi, S; Kako, M; Mitamura, K; Miyake, K; Miyazaki, J; Ota, Y; Sato, Y; Suzuki, H; Tanaka, K; Tango, T; Tomi, T; Umeda, T; Yoshiba, M | 1 |
| Chen, HM; Han, DW; Jiang, CF; Liu, JH; Ma, XH; Su, XS; Wang, LH; Zhao, MQ; Zhao, YC | 1 |
| Zeuzem, S | 1 |
| Kagami, M; Kayashima, S; Kobari, S; Kondou, T; Watanabe, Y | 1 |
| Harada, K; Ishida, M; Ito, H; Katayama, S; Kawasaki, H; Okubo, M; Shiota, G; Tomie, Y | 1 |
| Fujisawa, Y; Fujita, T; Matsushita, M; Nishioka, K; Sakamoto, M | 1 |
| Adachi, Y; Miyamoto, M; Sakata, I; Takahashi, H | 1 |
| Iwamura, K; Ohta, W | 1 |
1 review(s) available for glycyrrhizic acid and Hepatitis, Viral, Human
| Article | Year |
|---|---|
[A meta-analysis of diammonium glycyrrhizinate enteric-coated capsules versus diammonium glycyrrihizinate in patients with chronic viral hepatitis].
Topics: Capsules; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Randomized Controlled Trials as Topic | 2014 |
2 trial(s) available for glycyrrhizic acid and Hepatitis, Viral, Human
| Article | Year |
|---|---|
[Plasma levels of D-dimer and von Willebrand factor and the therapeutic effect of compound glycyrrhizin in children with cytomegalovirus hepatitis].
Topics: Child, Preschool; Cytomegalovirus Infections; Female; Fibrin Fibrinogen Degradation Products; Glycyrrhizic Acid; Hepatitis, Viral, Human; Humans; Infant; Liver Circulation; Male; von Willebrand Factor | 2010 |
Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
Topics: Alanine Transaminase; Antiviral Agents; Female; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome | 2002 |
9 other study(ies) available for glycyrrhizic acid and Hepatitis, Viral, Human
| Article | Year |
|---|---|
[Study of clinical character and medicinal therapy of viral hepatitis in hospital based on real world].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Glutathione; Glycyrrhizic Acid; Hepatitis, Viral, Human; Hospitals; Humans; Male; Middle Aged; Young Adult | 2014 |
[Analysis of characteristics of traditional Chinese medicine and western medicine clinical use in patients with viral hepatitis based on real world hospital information system data].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Drugs, Chinese Herbal; Female; Glutathione; Glycyrrhizic Acid; Hepatitis, Viral, Human; Hospital Information Systems; Humans; Infant; Male; Medicine, Chinese Traditional; Middle Aged; Young Adult | 2014 |
Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Animals; Antiviral Agents; Chronic Disease; Fatty Liver; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; Humans; Liver Cirrhosis, Experimental; Male; Middle Aged; Rats; Rats, Inbred Strains | 1984 |
[Glycyrrhizin for the treatment of allergic diseases and chronic hepatitis].
Topics: Anti-Allergic Agents; Antiviral Agents; Contraindications; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Hypersensitivity | 1998 |
A patient with non-A, non-B, non-C hepatitis-associated aplastic anemia recovered promptly following immuno-suppressive therapy, including antithymocyte globulin.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Autoimmune Diseases; Bone Marrow Cells; Combined Modality Therapy; Cyclosporine; Erythrocyte Transfusion; Glycyrrhizic Acid; Granulocyte Colony-Stimulating Factor; Hepatitis, Viral, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Subsets; Male; Methylprednisolone; Oxymetholone; Platelet Transfusion | 1998 |
Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Diethylnitrosamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Liver; Liver Function Tests; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Organ Size | 1999 |
Glycyrrhizin inhibits the lytic pathway of complement--possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Complement Inactivator Proteins; Complement Membrane Attack Complex; Glycyrrhizic Acid; Guinea Pigs; Hepatitis, Viral, Human; Hepatocytes; Humans; Sheep | 2000 |
Hepatitis-associated aplastic anemia and transfusion-transmitted virus infection.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; DNA Virus Infections; Glycyrrhizic Acid; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Methylprednisolone; Prednisolone; Torque teno virus | 2000 |
[Treatment of non-A, non-B hepatitis with glycyrrhizin].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Drug Evaluation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Male; Middle Aged | 1988 |